Properties of xyloglucan hydrogel as the biomedical sustained-release carriers

Journal of Materials Science: Materials in Medicine

Volumn 23, Issue 4, 2012, Pages 955-962

  Chen, Didi ^a   Guo, Pei ^a   Chen, Sha ^a   Cao, Yu ^a   Ji, Wanzhen ^a   Lei, Xia ^a   Liu, Lina ^a   Zhao, Peiguang ^a   Wang, Ruihong ^a   Qi, Chao ^a   Liu, Yanli ^a   He, Hongxuan ^b  

^a CENTRAL CHINA NORMAL UNIVERSITY   (China)

^b INSTITUTE OF ZOOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DELIVERY SYSTEM; DRUG RELEASE; GALACTOSIDASES; IN-VITRO; PHYSICAL AND CHEMICAL PROPERTIES; SEED GUM; SUSTAINED-RELEASE; XYLOGLUCANS;

CHEMICAL PROPERTIES; DRUG DELIVERY; HYDROGELS;

POLYMERS;

DRUG CARRIER; PARACETAMOL; UNCLASSIFIED DRUG; XYLOGLUCAN; XYLOGLUCAN HYDROGEL;

ARTICLE; CHROMATOGRAPHY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; HYDROGEL; IN VITRO STUDY; IN VIVO STUDY; LIGHT SCATTERING; MOLECULAR SIZE; MOLECULAR WEIGHT; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; VISCOSITY;

CHROMATOGRAPHY, GEL; DELAYED-ACTION PREPARATIONS; GLUCANS; HYDROGELS; MOLECULAR WEIGHT; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; VISCOSITY; XYLANS;

TAMARINDUS INDICA;

EID: 84863320832     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-012-4564-z     Document Type: Article

References (24)

1. Mishra A, Malhotra AV. Tamarind xyloglucan: a polysaccharide with versatile application potential. J Mater Chem. 2009;19: 8528-36.
2. Nishinari K, Takemasa M, Yamatoya K, Shirakawa M. Xyloglucan. In: Phillips GO, Williams PA, editors. Handbook of hydrocolloids. Cambridge: Woodhead Publishing; 2009. p. 535-66.
3. Lucyszyn N, Lubambo AF, Ono L, Jó TA, De Souza KF, Sierakowski MR. Chemical, physico-chemical and cytotoxicity characterisation of xyloglucan from Guibourtia hymenifolia (Moric.) J. Leonard seeds. Food Hydrocoll. 2011;25:1242-50.
4. Cao Y, Gu Y, Ma H, Bai J, Liu L, Zhao P, He H. Self-assembled nano drug delivery systems from galactosylated polysaccharide- doxorubicin conjugate loaded doxorubicin. Int J Biol Macromol. 2010;46:245-9.
5. Cao Y, Chen D, Zhao P, Liu L, Huang X, Qi C, Liu Y, He H, Wang Q, Liu Y, Chen S. Intracellular delivery of mitomycin C with targeted polysaccharide conjugates against multidrug resistance. Ann Biomed Eng. 2011;39(9):2456-65.
6. Cao Y, Ikeda I. Antioxidant activity and antitumor activity (in vitro) of xyloglucan selenious ester and surfated xyloglucan. Int J Biol Macromol. 2009;45:231-5.
7. Coviello T, Matricardi P, Alhaique F. Drug delivery strategies using polysaccharidic gels. Drug Deliv. 2006;3:395-404. (Pubitemid 43772714)
8. Sandolo C, Matricardi P, Alhaique F, Coviello T. Characterization of polysaccharide hydrogels for modified drug delivery. Food Hydrocoll. 2009;23:210-20.
9. Yoo MK, Choi HK, Kim TH. Drug release from xyloglucan beads coated with Eudragit for oral drug delivery. Arch Pharmacal Res. 2005;28:736-42.
10. Rinaudo M. Advances in characterization of polysaccharides in aqueous solution and gel state. In: Dumitriu S, Dekker M, editors. Polysaccharides structural diversity and functional versatility. NY: Marcel Dekker; 2004. p. 237-53.
11. Shirakawa M, Yamatoya K, Nishinari K. Tailoring of xyloglucan properties using an enzyme. Food Hydrocoll. 1998;12:25-8.
12. Kawasaki N, Ohkura R, Miyazaki S, Uno Y, Sugimoto Y, Attwood D. Thermally reversible xyloglucan gels as vehicles for oral drug delivery. Int J Pharm. 1999;181:227-34. (Pubitemid 29229809)
13. Amanda K, Brun-Graeppi AS, Richard C, Bessodes M, Scherman D, Narita T, Ducouret G, Merten O-W. Study on the sol-gel transition of xyloglucan hydrogels. Carbohydr Polym. 2010;80:556-63.
14. Yang Z, Yang L. Research status and prospective development of hydrogel. Chem Intermed (Chinese). 2007;1:5-10.
15. Liu W, Yao K, Qi W. Advances in hydrogel. Polym Mater Sci Eng (Chinese). 2002;18:54-57.
16. Seo SJ, Park IK, Yoo MK. Xyloglucan as a synthetic extracellular matrix for hepatocyte attachment. J biomater Sci Polym Ed. 2004;15:1375-87.
17. Coviello T, Matricardi P, Marianecci C, Alhaique F. Polysaccharide hydrogels for modified release formulations. J Controlled Release. 2007;119:5-24. (Pubitemid 46561537)
18. Miyazaki S, Yokouchi C, Nakamura T, Hashiguchi N, Hou WM, Takada M. Pluronic F-127 gels as a novel vehicle for rectal administration of indomethacin. Chem Pharm Bull. 1986;34: 1801-8. (Pubitemid 16118547)
19. Kang F, Singh J. In vitro release of insulin and biocompatibility of in situ forming gel systems. Int J Pharm. 2005;304:83-90. (Pubitemid 41427652)
20. Miyazaki S, Tobiyama T, Takada M, Attwood D. Percutaneous absorption of indomethacin from Pluronic F127 gels in rats. J Pharm Pharmacol. 1995;47:455-7.
21. Miyazaki S, Ohkawa Y, Takada M, Attwood D. Antitumor activity of Pluronic F127 gel containing mitomycin C on sarcoma- 180 ascites tumor in mice. Chem Pharm Bull. 1992;40: 2224-6.
22. He M, Zhang H, Chen X, Dong X. Polymer physics (Chinese). 3rd ed. Fudan University Press; 2007.
23. Itoh K, Tsuruya R, Shimoyama T, Watanabe H, Miyazaki S, D'Emanuele A, Attwood D. In situ gelling xyloglucan/alginate liquid formulation for oral sustained drug delivery to dysphagic patients. Drug Dev Ind Pharm. 2009;36:355-449.
24. Miyazaki S, Endo K, Kawasaki N, Kubo W, Watanabe H, Attwood D. Oral sustained delivery of paracetamol from in situ gelling xyloglucan formulations. Drug Dev Ind Pharm. 2003;29:113-9. (Pubitemid 36292934)